Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADR
-
Number of holders
-
757
-
Total 13F shares, excl. options
-
316,397,805
-
Shares change
-
+15,360,404
-
Total reported value, excl. options
-
$11,302,294,765
-
Value change
-
+$543,454,028
-
Put/Call ratio
-
81%
-
Number of buys
-
329
-
Number of sells
-
-368
-
Price
-
$35.69
Significant Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2021
876 filings reported holding GSK - GLAXOSMITHKLINE PLC - ADR as of Q1 2021.
GLAXOSMITHKLINE PLC - ADR (GSK) has 757 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 316,397,805 shares
.
Largest 10 shareholders include Dodge & Cox (87,947,245 shares), Capital International Investors (19,889,711 shares), FMR LLC (17,148,952 shares), Fisher Asset Management, LLC (17,021,985 shares), PRICE T ROWE ASSOCIATES INC /MD/ (15,543,281 shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (10,180,100 shares), ROYAL BANK OF CANADA (9,757,031 shares), STATE STREET CORP (9,373,894 shares), RENAISSANCE TECHNOLOGIES LLC (8,763,021 shares), and Black Creek Investment Management Inc. (8,668,499 shares).
This table shows the top 757 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.